Foerster, Friedrich; Kloeckner, Roman; Reig, Maria et al.
ABC-HCC: A phase IIIb, randomized, multicenter, open-label trial of atezolizumab plus bevacizumab versus transarterial chemoembolization (TACE) in intermediate-stage hepatocellular carcinomaJOURNAL OF CLINICAL ONCOLOGY. Bd. 40. H. 4. 2022
Schleicher, Eva Maria; Bayer, Thomas A.; Iseni, Trendelina et al.
Ablation of the Presynaptic Protein Mover Impairs Learning Performance and Decreases Anxiety Behavior in MiceINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 23. H. 19. 2022
Lazarus, ?; Mark, Henry E.; Anstee, Quentin M. et al.
Advancing the global public health agenda for NAFLD: a consensus statementNATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY. Bd. 19. H. 1. 2022 S. 60-78
Ratziu, Vlad; Anstee, Quentin M.; Wong, Vincent Wai-Sun et al.
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT projectHEPATOLOGY. Bd. 76. H. 6. 2022 S. 1766-1777
Emmenegger, Marc; Kumar, Sreedhar Saseendran; Emmenegger, Vishalini et al.
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins (vol 17, e1010118, 2021)PLOS PATHOGENS. Bd. 18. H. 2. 2022
Kaps, Leonard; Hildebrand, Katharina; Nagel, Michael et al.
Applicability and Determination of country-specific Thresholds of the EncephalApp Stroop Test as a Screening Tool for minimal hepatic Encephalopathy in Patients with CirrhosisINTERNIST. Bd. 63. H. SUPPL 3. 2022 S. 331-331
Yoon, Harry H.; Jin, Zhaohui; Kour, Oudom et al.
Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical TrialsJAMA ONCOLOGY. 2022
Yoon, Harry H.; Jin, Zhaohui; Kour, Oudom et al.
Association of PD-L1 Expression and OtherVariables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical TrialsJAMA ONCOLOGY. Bd. 8. H. 10. 2022 S. 1456-1465
de Castro, Tiago; Jochheim, Leonie S.; Bathon, Melanie et al.
Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experienceTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. Bd. 14. 2022
Mueller, Lukas; Gairing, Simon Johannes; Kloeckner, Roman et al.
Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under ImmunotherapyCANCERS. Bd. 14. H. 15. 2022